Show simple item record

dc.contributor.advisorHutt, Peter Bartonen_US
dc.contributor.authorGreen, Juliaen_US
dc.date.accessioned2012-07-06T20:09:14Z
dc.date.issued2002en_US
dc.identifier.citationBabies, Blemishes and FDA: A History of Accutane Regulation in the United States (2002 Third Year Paper)en
dc.identifier.urihttp://nrs.harvard.edu/urn-3:HUL.InstRepos:8963867
dc.description.abstractThis paper takes a journalistic approach, tracing the chronology of Accutane in the U.S. in order to fill in the gaps of the story that has inspired so much controversy. Accutane has repeatedly pushed the frontier of FDA regulation, as the agency struggled to adapt its tools to meet the challenge of an extremely effective and extremely dangerous medication. By emphasizing the evolving American response to the high level of risk associated with Accutane, I hope to provide the material needed to evaluate the strengths and weaknesses of our current regulatory framework.en
dc.language.isoen_USen
dash.licenseLAAen_US
dc.subjectFood and Drug Lawen
dc.subjectAccutaneen
dc.subjectFDAen
dc.subjectdangersen
dc.subjectbirthen
dc.subjectdefectsen
dc.titleBabies, Blemishes and FDA: A History of Accutane Regulation in the United Statesen
dc.typePaper (for course/seminar/workshop)en_US
dc.date.available2012-07-06T20:09:14Z
dash.authorsorderedfalse
dash.contributor.affiliatedGreen, Julia


Files in this item

Thumbnail
Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record